AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11887498 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids administered systemically in the first two weeks after birth
Number of subjects: 0
Study 9632998 — intervention group
Group type: EXPERIMENTAL
Intervention: Potent combination antiretroviral therapy
Number of subjects: 0
Study 9632998 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole or alternative agents
Number of subjects: 0
Study 9632998 — intervention group
Group type: COMPARATOR
Intervention: Specific antimicrobial prophylaxis for MAC
Number of subjects: 0
Study 9632998 — intervention group
Group type: COMPARATOR
Intervention: Prophylaxis for PCP, disseminated MAC infection, and CMV end-organ disease
Number of subjects: 0
Study 7912876 — intervention group
Group type: EXPERIMENTAL
Intervention: Dixyrazine (15-30 mg)
Number of subjects: 100
Study 7912876 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (4-10 mg)
Number of subjects: 100
Study 2510135 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 90 mg every 8 hours for 5 days
Number of subjects: 9
Study 2510135 — intervention group
Group type: COMPARATOR
Intervention: Encainide 25 mg every 8 hours for 5 days
Number of subjects: 9
Study 1254724 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrin antiserum (0.02, 0.1, and 0.5 ml/kg)
Number of subjects: 0
Study 1254724 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human gastrin I (0.25 mug-kg-1-h-1)
Number of subjects: 0
Study 1254724 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrin antiserum (0.1 ml/kg)
Number of subjects: 0
Study 1254724 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrin antiserum (0.2 ml/kg)
Number of subjects: 0
Study 1254724 — intervention group
Group type: COMPARATOR
Intervention: Control antiserum
Number of subjects: 0
Study 31343936 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline condition of the Tower of London task
Number of subjects: 81
Study 31343936 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulatory suppression secondary task (disrupted verbal mediation)
Number of subjects: 81
Study 31343936 — intervention group
Group type: COMPARATOR
Intervention: Motor suppression secondary task (control for secondary task demand)
Number of subjects: 81
Study 28627793 — intervention group
Group type: EXPERIMENTAL
Intervention: yohimbine
Number of subjects: 20
Study 28627793 — intervention group
Group type: EXPERIMENTAL
Intervention: phenylephrine
Number of subjects: 20
Study 27045264 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily (OaD)
Number of subjects: 422
Study 27045264 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg on-demand (PRN)
Number of subjects: 422
Study 27045264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study 22998616 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 implant (Group 1)
Number of subjects: 36
Study 22998616 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 implants (Group 2)
Number of subjects: 36
Study 22971152 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness program as part of the SEYLE intervention study
Number of subjects: 0
Study 20680193 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS methylphenidate (MPH)
Number of subjects: 34
Study 18198454 — intervention group
Group type: EXPERIMENTAL
Intervention: CBBD scale applied to caregivers of care-recipients with cognitive disorders
Number of subjects: 1818
Study 18198454 — intervention group
Group type: COMPARATOR
Intervention: CBBD scale applied to caregivers of care-recipients without cognitive disorders
Number of subjects: 1818
Study 18198454 — intervention group
Group type: EXPERIMENTAL
Intervention: CBBD scale items related to symptoms of dementia
Number of subjects: 1818
Study 16253026 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication therapy
Number of subjects: 28
Study 12390389 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative resection
Number of subjects: 285
Study 10444231 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine (10 mg/day)
Number of subjects: 91
Study 10444231 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine (5-45 mg)
Number of subjects: 91
Study 10444231 — intervention group
Group type: COMPARATOR
Intervention: First generation antihistamines (clemastine, tripolidine) and second generation antihistamines (terfenadine, cetirizine)
Number of subjects: 91
Study 7842761 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-month reevaluation interval
Number of subjects: 50
Study 7842761 — intervention group
Group type: COMPARATOR
Intervention: 6-month reevaluation interval
Number of subjects: 50
Study 1978488 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride (30-90 mg, 120-240 mg, 300-600 mg, divided into three doses per day)
Number of subjects: 79
Study 1978488 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride (maximum dose for 4 weeks or more)
Number of subjects: 79
Study 1978488 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride (dose reductions or discontinuations due to adverse symptoms)
Number of subjects: 79
Study 792736 — intervention group
Group type: EXPERIMENTAL
Intervention: parsalmide
Number of subjects: 40
Study 792736 — intervention group
Group type: COMPARATOR
Intervention: indomethacin
Number of subjects: 40
Study 31190491 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaoren Tongdu acupuncture
Number of subjects: 50
Study 31190491 — intervention group
Group type: COMPARATOR
Intervention: Femoston (oral estradiol and dydrogesterone tablets)
Number of subjects: 50
Study 29246219 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of Pycnogenol® twice daily
Number of subjects: 33
Study 29246219 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 33
Study 25937516 — intervention group
Group type: EXPERIMENTAL
Intervention: Active and Healthy Families (AHF)
Number of subjects: 55
Study 25937516 — intervention group
Group type: COMPARATOR
Intervention: Usual care wait-list control
Number of subjects: 55
Study 22688211 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Injury Partners program (Web-based intervention)
Number of subjects: 201
Study 22688211 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 201
Study 22097612 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir 1.0 mg/d
Number of subjects: 65
Study 22097612 — intervention group
Group type: COMPARATOR
Intervention: Adefovir dipivoxil 10 mg/d
Number of subjects: 65
Study 19819095 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit language used by physicians when delivering bad news
Number of subjects: 16
Study 19819095 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit language in bad news delivery
Number of subjects: 16
Study 19819095 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding of bad news by patients
Number of subjects: 16
Study 16537846 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium alone
Number of subjects: 95
Study 16537846 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium plus formoterol once daily
Number of subjects: 95
Study 16537846 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium plus formoterol twice daily
Number of subjects: 95
Study 12492791 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 6.0 mg + fentanyl 25 micro g
Number of subjects: 40
Study 12492791 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 7.5 mg + fentanyl 25 micro g
Number of subjects: 40
Study 11203813 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgambond Plus and Tytin amalgam (small restorations)
Number of subjects: 60
Study 11203813 — intervention group
Group type: COMPARATOR
Intervention: Tytin amalgam (small restorations)
Number of subjects: 60
Study 11203813 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgambond Plus and Tytin amalgam (large restorations)
Number of subjects: 60
Study 11203813 — intervention group
Group type: COMPARATOR
Intervention: Tytin amalgam (large restorations)
Number of subjects: 60
Study 9339929 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery catheter (PAC) placed preoperatively with hemodynamic optimization (Group I)
Number of subjects: 104
Study 9339929 — intervention group
Group type: COMPARATOR
Intervention: Standard care without routine PAC placement (Group II)
Number of subjects: 104
Study 8095449 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 1 mg of terbutaline (4 puffs)
Number of subjects: 10
Study 8095449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3953532 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan
Number of subjects: 13
Study 3953532 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylalanine
Number of subjects: 13
Study 3953532 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 13
Study 31628456 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited future time perspective
Number of subjects: 438
Study 31628456 — intervention group
Group type: EXPERIMENTAL
Intervention: Death reflection
Number of subjects: 438
Study 31628456 — intervention group
Group type: COMPARATOR
Intervention: Mortality salience
Number of subjects: 438
Study 30049669 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified intervention
Number of subjects: 94
Study 30049669 — intervention group
Group type: COMPARATOR
Intervention: Nongamified intervention
Number of subjects: 94
Study 26955982 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal psychoeducation
Number of subjects: 41
Study 26955982 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (TAU)
Number of subjects: 41
Study 26220054 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual plane flap inset
Number of subjects: 50
Study 26220054 — intervention group
Group type: COMPARATOR
Intervention: Single plane flap inset
Number of subjects: 50
Study 23055402 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 117
Study 23055402 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 117
Study 23055402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 20670761 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ventricular reconstruction (SVR) added to CABG
Number of subjects: 2036
Study 20670761 — intervention group
Group type: COMPARATOR
Intervention: CABG without SVR
Number of subjects: 2036
Study 20670761 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazard ratios of 1,000 STICH patients in 3 RAR groups
Number of subjects: 2036
Study 18484252 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporal shock-wave therapy (ESWT)
Number of subjects: 48
Study 18484252 — intervention group
Group type: COMPARATOR
Intervention: Sham ESWT (placebo)
Number of subjects: 48
Study 16839262 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral greater occipital nerve (GON) block with 0.25% bupivacaine
Number of subjects: 82
Study 16839262 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prior block)
Number of subjects: 82
Study 12777360 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained quitters (smoking cessation in the first year)
Number of subjects: 5346
Study 12777360 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained quitters
Number of subjects: 5346
Study 12777360 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine reactivity
Number of subjects: 5346
Study 10857365 — intervention group
Group type: EXPERIMENTAL
Intervention: Suntan parlor exposures (10 full-body UV exposures over a 2 week period, shielding only the right flexural arm)
Number of subjects: 22
Study 10857365 — intervention group
Group type: COMPARATOR
Intervention: No exposure (control group)
Number of subjects: 22
Study 9021700 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin
Number of subjects: 10
Study 8256187 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime 2 grams every 12 hours IVPB plus metronidazole 0.5 grams every eight hours IVPB (C/M)
Number of subjects: 96
Study 8256187 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin 1.5 milligrams per kilogram IVPB plus clindamycin 0.9 grams every eight hours IVPB (G/C)
Number of subjects: 96
Study 8256187 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime plus metronidazole (C/M)
Number of subjects: 96
Study 8256187 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin plus clindamycin (G/C)
Number of subjects: 96
Study 3155916 — intervention group
Group type: EXPERIMENTAL
Intervention: Group conference phone calls with self-determined task assignments for 8 weeks
Number of subjects: 38
Study 29698112 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-cm Visual Analog Scale (VAS)
Number of subjects: 70
Study 29698112 — intervention group
Group type: EXPERIMENTAL
Intervention: GOSLON Yardstick
Number of subjects: 70
Study 29698112 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D digital models
Number of subjects: 70
Study 29698112 — intervention group
Group type: COMPARATOR
Intervention: Conventional plaster models
Number of subjects: 70
Study 30065246 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 231
Study 30065246 — intervention group
Group type: COMPARATOR
Intervention: Internet-delivered Parent Training (iComet)
Number of subjects: 231
Study 27325103 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 fractional laser photothermolysis followed by 4 weeks topical application of B‐Resorcinol and Glycyrrhetinic acid
Number of subjects: 11
Study 27325103 — intervention group
Group type: COMPARATOR
Intervention: Topical application of B‐Resorcinol and Glycyrrhetinic acid only
Number of subjects: 11
Study 25411293 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 500 μg vitamin B‐12 plus 400 μg folic acid supplementation for 2 years (including 600 IU vitamin D3)
Number of subjects: 2919
Study 25411293 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation for 2 years (including 600 IU vitamin D3)
Number of subjects: 2919
Study 25411293 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 500 μg vitamin B‐12 plus 400 μg folic acid supplementation for 2 years
Number of subjects: 2919
Study 25411293 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation for 2 years
Number of subjects: 2919
Study 23290324 — intervention group
Group type: EXPERIMENTAL
Intervention: Metadoxine ER 1,400 mg/d for 6 weeks
Number of subjects: 120
Study 23290324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 23290324 — intervention group
Group type: EXPERIMENTAL
Intervention: Metadoxine ER
Number of subjects: 120
Study 20231213 — intervention group
Group type: EXPERIMENTAL
Intervention: Pendulum appliance supported with a K-loop buccally (group 1)
Number of subjects: 30
Study 20231213 — intervention group
Group type: COMPARATOR
Intervention: Cervical headgear (CHG) (group 2)
Number of subjects: 30
Study 18976162 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 15 microg/kg + Ondansetron 12 mg
Number of subjects: 135
Study 18976162 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 12.5 microg/kg + Ketorolac 1.5 mg/kg + Ondansetron 12 mg
Number of subjects: 135
Study 18976162 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 10 microg/kg + Ketorolac 3 mg/kg + Ondansetron 12 mg
Number of subjects: 135
Study 16096176 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin releasing hormone (GnRH, goserelin 3.6 mg) administered subcutaneously every 28 days for 12 weeks
Number of subjects: 12
Study 11835027 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous testosterone (2 doses designed to increase testosterone 2 or 6 times baseline)
Number of subjects: 32
Study 11835027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 11273540 — intervention group
Group type: EXPERIMENTAL
Intervention: Test brand (Panacea Biotec Ltd.)
Number of subjects: 12
Study 11273540 — intervention group
Group type: COMPARATOR
Intervention: Reference brand (Pfizer India Ltd.)
Number of subjects: 12
Study 11273540 — intervention group
Group type: EXPERIMENTAL
Intervention: Both brands
Number of subjects: 12
Study 9065542 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational exposure to copper for more than 20 years
Number of subjects: 608
Study 9065542 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational exposure to manganese for more than 20 years
Number of subjects: 608
Study 9065542 — intervention group
Group type: EXPERIMENTAL
Intervention: Combinations of lead-copper exposure for more than 20 years
Number of subjects: 608
Study 9065542 — intervention group
Group type: EXPERIMENTAL
Intervention: Combinations of lead-iron exposure for more than 20 years
Number of subjects: 608
Study 9065542 — intervention group
Group type: EXPERIMENTAL
Intervention: Combinations of iron-copper exposure for more than 20 years
Number of subjects: 608
Study 8349063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical brush
Number of subjects: 301
Study 8349063 — intervention group
Group type: COMPARATOR
Intervention: Plastic spatula
Number of subjects: 301
Study 8349063 — intervention group
Group type: COMPARATOR
Intervention: Cotton swab
Number of subjects: 301
Study 8349063 — intervention group
Group type: EXPERIMENTAL
Intervention: All instruments
Number of subjects: 301
Study 3034034 — intervention group
Group type: COMPARATOR
Intervention: Ramipril 5 mg (3 times at 12-hour intervals)
Number of subjects: 16
Study 3034034 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg daily for 2 weeks
Number of subjects: 16
Study 3034034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31195892 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocular viewing
Number of subjects: 23
Study 31195892 — intervention group
Group type: EXPERIMENTAL
Intervention: Binocular viewing with monocular blur
Number of subjects: 23
Study 31195892 — intervention group
Group type: COMPARATOR
Intervention: Binocular viewing
Number of subjects: 23
Study 29326192 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfers conditional on school attendance
Number of subjects: 3889
Study 27391675 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Activation Treatment for Depression (Activate) - 10 individual 60-min therapy sessions with a psychologist, in addition to treatment as usual (TAU)
Number of subjects: 200
Study 27391675 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 200
Study 24398888 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 200
Study 24398888 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 200
Study 24398888 — intervention group
Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 200
Study 22438366 — intervention group
Group type: EXPERIMENTAL
Intervention: CT colonography
Number of subjects: 547
Study 22438366 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopy
Number of subjects: 547
Study 20303597 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration-assisted anesthesia
Number of subjects: 80
Study 20303597 — intervention group
Group type: COMPARATOR
Intervention: Placebo (static vibration off)
Number of subjects: 80
Study 18658066 — intervention group
Group type: EXPERIMENTAL
Intervention: Language-Focused Curriculum (LFC) implemented by treatment teachers for an academic year.
Number of subjects: 196
Study 18658066 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher use of language stimulation techniques (LSTs) such as open questions, recasts, models.
Number of subjects: 196
Study 18658066 — intervention group
Group type: COMPARATOR
Intervention: Control group maintained their prevailing curriculum.
Number of subjects: 196
Study 15919007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiary care (Group A)
Number of subjects: 87
Study 15919007 — intervention group
Group type: COMPARATOR
Intervention: Primary care (Group B)
Number of subjects: 87
Study 12888401 — intervention group
Group type: EXPERIMENTAL
Intervention: Video education (6 sessions)
Number of subjects: 197
Study 12888401 — intervention group
Group type: COMPARATOR
Intervention: Oral presentation (8 sessions)
Number of subjects: 197
Study 12888401 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 197
Study 10573549 — intervention group
Group type: EXPERIMENTAL
Intervention: Atole (high energy, high protein supplement)
Number of subjects: 240
Study 10573549 — intervention group
Group type: COMPARATOR
Intervention: Fresco (low energy, no-protein supplement)
Number of subjects: 240
Study 10573549 — intervention group
Group type: COMPARATOR
Intervention: Completion of primary school
Number of subjects: 240
Study 8767568 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive group (100 mg tramadol at extubation + continuous infusion of 200 mg tramadol)
Number of subjects: 94
Study 8767568 — intervention group
Group type: COMPARATOR
Intervention: On-demand group (placebo at extubation + bolus tramadol on demand)
Number of subjects: 94
Study 8767568 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive group
Number of subjects: 94
Study 8767568 — intervention group
Group type: COMPARATOR
Intervention: On-demand group
Number of subjects: 94
Study 1920782 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (5 micrograms.kg‐1)
Number of subjects: 30
Study 1920782 — intervention group
Group type: COMPARATOR
Intervention: Control (no clonidine)
Number of subjects: 30
Study 31079083 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with Doin therapy
Number of subjects: 124
Study 31079083 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 124
Study 28209560 — intervention group
Group type: EXPERIMENTAL
Intervention: Full ASPIRE program (experimental condition, n=50)
Number of subjects: 101
Study 28209560 — intervention group
Group type: COMPARATOR
Intervention: Online text-based version of ASPIRE (control condition, n=51)
Number of subjects: 101
Study 28209560 — intervention group
Group type: EXPERIMENTAL
Intervention: Full ASPIRE program (experimental condition)
Number of subjects: 101
Study 25590331 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health intervention promoting expedited partner therapy (EPT) with free patient-delivered partner therapy (PDPT) available to clinicians.
Number of subjects: 23
Study 23688367 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Pain Management Program (IPMP) for staff and residents, consisting of 8 weeks of activities including gardening therapy and physiotherapy exercise.
Number of subjects: 90
Study 23688367 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Pain Management Program (IPMP) for residents.
Number of subjects: 90